您現(xiàn)在的位置: > Language Tips > Audio & Video > Special Speed News  
 





  Once-daily pill could simplify HIV treatment
[ 2006-02-06 15:57 ]


I’m Steve Ember with the VOA Special English Health Report.


Myers Squibb and Gilead Sciences have combined many H.I.V. drugs into a single pill
Sometimes the best medicine is more than one kind of medicine. Malaria, tuberculosis and H.I.V./AIDS, for example, are all treated with combinations of drugs.

But that can mean a lot of pills to take. It would be simpler if drug companies combined all the medicines into a single pill, taken just once a day.

Now, two companies say they have done that for people just starting treatment for H.I.V., the virus that causes AIDS. The companies are Bristol-Myers Squibb and Gilead Sciences.

They have developed a single pill that combines three drugs currently on the market. Bristol-Myers Squibb sells one of them under the name Sustiva. Gilead combined the others, Emtriva and Viread, into a single pill in two thousand four.

Combining drugs involves more than technical issues. It also involves issues of competition if the drugs are made by different companies. The new once-daily pill is the result of what is described as the first joint venture agreement of its kind in the treatment of H.I.V.

In January the New England Journal of Medicine published a study of the new pill. Researchers compared its effectiveness to that of the widely used combination of Sustiva and Combivir. Combivir contains two drugs, AZT and 3TC. The researchers say that after one year of treatment, the new pill suppressed H.I.V. levels in more patients and with fewer side effects.

Gilead paid for the study. Professor Joel Gallant at the Johns Hopkins School of Medicine in Baltimore, Maryland, led the research. He is a paid adviser to Gilead and Bristol-Meyers Squibb as well as the maker of Combivir, GlaxoSmithKline.

GlaxoSmithKline reacted to the findings by saying that a single study is of limited value. It says the effectiveness of Combivir has been shown in each of more than fifty studies.

The price of the new once-daily pill has not been announced. But Gilead and Bristol-Myers Squibb say they will provide it at reduced cost to developing countries.

They plan in the next few months to ask the United States Food and Drug Administration to approve the new pill.

There are limits to who could take it because of the different drugs it contains. For example, pregnant women are told not to take Sustiva because of the risk of birth disorders.

Experts say more than forty million people around the world are living with H.I.V.

This VOA Special English Health Report was written by Cynthia Kirk. Read and listen to our reports at voaspecialenglish.com. I’m Steve Ember.

Vocabulary

 

 

 
 
 




主站蜘蛛池模板: 成人动漫在线免费观看| 波多野结衣一区二区三区高清av | 国产精品无码一区二区三级| 中文字幕日韩人妻不卡一区| 欧美乱妇高清视频免欢看关| 免费吃奶摸下激烈免费视频| 野花社区视频www| 国产精品妇女一二三区| www亚洲成人| 日日橹狠狠爱欧美超碰| 亚洲另类春色国产精品| 窝窝女人体国产午夜视频| 国产传媒在线播放| 六月丁香综合网| 天天天操天天天干| 中文字幕一区二区人妻性色| 日韩精品无码人成视频手机| 亚洲欧美日韩国产精品网| 精品久久一区二区三区| 国产一级做a爰片在线| 免费观看激色视频网站(性色)| 在线观看精品国产福利片87 | 永久在线毛片免费观看| 午夜视频在线在免费| 高嫁肉柳风车动漫| 国产精品综合网| chinesespanking2实践| 成年日韩片av在线网站| 久久精品无码中文字幕| 欧美性猛交xxxx乱大交丰满| 人妻有码中文字幕| 精品无码久久久久久久久| 国产人妖ts视频在线观看| 四虎1515hh永久久免费| 国产香蕉尹人在线观看视频| sss欧美一区二区三区| 成人黄18免费视频| 久久久噜噜噜久久熟女AA片| 最近免费中文字幕大全视频| 亚洲成人第一页| 热99re久久精品精品免费|